Last reviewed · How we verify
Astaxanthin Oral Capsule — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Astaxanthin Oral Capsule (Astaxanthin Oral Capsule) — Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Astaxanthin Oral Capsule TARGET | Astaxanthin Oral Capsule | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Astaxanthin Oral Capsule CI watch — RSS
- Astaxanthin Oral Capsule CI watch — Atom
- Astaxanthin Oral Capsule CI watch — JSON
- Astaxanthin Oral Capsule alone — RSS
Cite this brief
Drug Landscape (2026). Astaxanthin Oral Capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/astaxanthin-oral-capsule. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab